Life sciences: FDA debarment and investigator disqualification, in the same join as exclusion screening
Manufacturers screen the people they pay — speakers, consultants, advisory-board members, clinical investigators — against the OIG exclusion list and SAM.gov, and vet investigators against FDA's debarment list and its clinical investigator disqualification proceedings. Four lists, four formats, four places to look. RosterProof carries all four in one schema, beside 40 state Medicaid exclusion lists, so a provider check is a single query.
What is loaded, right now
Active records on the published surface, refreshed weekly. Plus 38 state Medicaid lists and DC.
HCP engagement screening. Anyone a manufacturer pays for services — a speaker, a consultant, an investigator — must be screened against the OIG LEIE and SAM.gov before and during the engagement; paying an excluded party can trigger civil monetary penalties and, for federally funded work, false-claims exposure. State Medicaid exclusions matter too: an excluded clinician is often excluded by a state first, a median five months before the federal list catches up, and sometimes never.
Clinical-trial investigator vetting. Sponsors may not use investigators FDA has disqualified (21 CFR 312.70, 812.119), and persons debarred under 21 U.S.C. 335a may not provide services in any capacity to a person with an approved or pending drug application. FDA publishes both lists, but as web tables with no NPI, no license and no address — exactly as they are published, we load them: the debarment term verbatim (Permanent^, 5 years%, footnote marks included), the investigator's current FDA status verbatim, Federal Register citations and letter links preserved.
One join
A provider check across every list at once. Subscribers prepend their mounted database name
(for a free listing mounted as ROSTERPROOF):
WITH roster AS (
SELECT 'ACOSTA' AS last_name, 'GINA' AS first_name
UNION ALL SELECT 'SMITH', 'JOHN'
)
SELECT r.last_name, r.first_name, e.source_id, e.exclusion_authority, e.exclusion_reason,
e.exclusion_start, e.npi, e.match_confidence
FROM roster r
JOIN ROSTERPROOF.PUBLISHED_V1.EXCLUSIONS_SCREENABLE e
ON UPPER(e.last_name) = r.last_name AND UPPER(e.first_name) = r.first_name
WHERE e.is_active
ORDER BY r.last_name, e.source_id;The FDA rows identify themselves: EXCLUSION_AUTHORITY = 'FDA / Debarment' or
'FDA / Clinical Investigator Disqualification'. Filter on that column to see only
FDA actions, or on SOURCE_ID for any single list.
What the two lists have in common with the others
Of the 224 people on the FDA debarment list, 67 also appear on the OIG LEIE, SAM.gov or a state Medicaid list under a name rare enough to trust (ten or fewer namesakes in the entire national NPI registry) — about 30%. For disqualified investigators it is 19 of 180 (11%). In many of those cases the OIG action came first and FDA's debarment followed the conviction months or years later.
Caveat: FDA publishes no NPI, so this is a name-based cross-check (surname + first name, middle initial not conflicting), graded by how rare the name is in NPPES; common-name coincidences are excluded from the count. October 2026 edition, reproducible from the published dataset.
Where this fits
RosterProof is the exclusion and owner-screening layer that feeds compliance, payment-integrity, and fraud programs — not a fraud detector. It tells you who is on a list, which list, since when, and how confidently the record maps to an NPI; your engagement-review, debarment-certification and investigator-selection workflows decide what to do with that. The data is free on the Snowflake Marketplace; sources and required notices are on the attribution page.